Urethral Dilators Market Trends

Growth Drivers

Spiking Cases of Prostate Cancer – In some cases, prostate cancer may lead to urethral strictures, which necessitate the use of urology devices including urethral dilators to manage urinary function. For instance, depending on the type of cancer treatment used, there is more than a 5% risk of urethral stricture after prostate cancer therapy. In 2020, there were over 1 million new cases of prostate cancer detected worldwide.
Growing Geriatric Population- Aged people may have weakened immune systems which can decrease the capacity of the bladder and weaken the pelvic floor muscles. This can lead to several urological disorders, leading to increased demand for urethral dilators. Lately, the number of individuals over 65 across the globe is more than 610 million, or roughly 8% of the population.

Challenges

Availability of Alternative Treatment Options – There are many other treatment options such as laser therapies, behavioral therapy, medication, surgical options for rUTI management, and endoscopic or percutaneous are easily available for the treatment of urological condition. This, as a result, limits the adoption of urethral dilators.
Stringent Regulatory Standards
Lack of Awareness

Urethral Dilators Market: Key Insights

Base Year	2022
Forecast Year	2023-2035
CAGR	~6%
Base Year Market Size (2022)	~ USD 0.218 Billion
Forecast Year Market Size (2035)	~ USD 0.593 Billion
Regional Scope	North America (U.S., and Canada) Latin America (Mexico, Argentina, Rest of Latin America) Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific) Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Frequently Asked Questions (FAQ)

Increasing prevalence of chronic kidney disorders and the rising popularity of minimally invasive procedures are the major factors driving the growth of the market.

The market size of Urethral Dilators is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2023 â€“ 2035.

The major players in the market are Enfucell Oy, STMicroelectronics International N.V., LG Chem, Ltd., Cymbet Corporation, Imprint Energy Inc, Jenax Inc., Samsung SDI Co., Ltd., Excellatron Solid State, LLC, and others.

The disposable segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

Urethral Dilators Market Trends